In New Jersey, Patent Defendants’ Bid For Attorney Fees Denied

Mealey's (October 28, 2019, 1:29 PM EDT) -- TRENTON, N.J. — Efforts by several generic drug makers to recoup the attorney fees they incurred in successfully defending allegations of patent infringement failed Oct. 25, when a federal judge in New Jersey declined to find the case exceptional, in what she deemed a “close call” (Reckitt Benckiser LLC v. Amneal Pharmaceuticals LLC, et al., No. 15-2155, D. N.J., 2019 U.S. Dist. LEXIS 184628)....